In preclinical cancer model studies of breast cancer, the upregulation of CCL2 expressed by tumor cells has been found to promote the recruitment of TAMs; moreover, VEGF-C and VEGF-D secreted by TAMs have been found to promote the lymphatic metastasis of tumor cells. Here, VEGFC is linked to neoplasm.